Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Been here a while lurking
View:
Post by N0taP00p on Nov 09, 2022 11:12am

Been here a while lurking

Been in this stock for years. Like another Canadian startup I invested in that was in the medical devices field, this one also seems to be another poorly managed startup with constant delays, bad communications, constant cash raises and a board of directors that don't seem to reflect the experience needed. What was shocking was when the management sued some posters on a message board years ago. Like this other Canadian company, Theralase also seems to have a promising product that can solve world hunger but just can't get over the finish line. My only hope is Dr. McFarland and the US based advisory doctor who seems to be a prominent urologist. The data seems to be good too. I'm hoping for the best. But if they past is any indication, we will see another delay and another excuse. I'm hoping for all our sakes, that's not the case.
Comment by ScienceFirst on Nov 09, 2022 11:20am
lolll Member Since: November 09, 2022
Comment by BlueFranky on Nov 09, 2022 11:35am
SF... just pressed the Iggy button .. most satisfying
Comment by N0taP00p on Nov 09, 2022 12:16pm
You must be the bubbly and brilliant cheerleader some call Bencro. Do you know we can read stuff without being a member? Anyway, whatever floats your boat. If you have balanced opinions and thoughts, I'm all ears.
Comment by Oilminerdeluxe on Nov 09, 2022 2:26pm
Waht do you mean in regards to "another excuse?"
Comment by N0taP00p on Nov 09, 2022 3:57pm
I'm just hoping there is no update that says we pushed everything out by X months for whatever reasons. The science seems to be solid and the doctors and scientists behind this seem to be solid as well. I just wish there was better and timely communications and good execution to build confidence and trust in that solid core. If anyone else thinks they're doing a wonderful job, fine by me ...more  
Comment by gebremeskel on Nov 09, 2022 4:18pm
We're all hoping that. Shareholders are hoping that and everyone at Theralase is hoping that. Theralase will stick to the Q4 submission milestone if they possibly can because it is in their interest to do so. It's in their interest to get BTD. It's in their interest to get FDA approval to commercialize a treatment for bladder cancer. And it's in their interest to accomplish this as ...more  
Comment by BlueFranky on Nov 09, 2022 4:24pm
Great post, Gerbremeskrel
Comment by FGPstock on Nov 09, 2022 5:38pm
Grebre, I agree we are all hoping that they can keep the timelines. But, why would they want to try to raise $5mm at .25 if they thought it was immenent that BTD and revenues were on the way? Also, Dr Vera leaving concerns me as she was the most reputable person at TLT and it doesn't make sense she would leave if TLT was on the cusp of providing the next SOC for bladder cancer. I still hold ...more  
Comment by gebremeskel on Nov 09, 2022 6:35pm
"why would they want to try to raise $5mm at .25 if they thought it was immenent that BTD and revenues were on the way?" It may not be what anyone wants to hear, but I think it's because they don't have any choice. So far nobody is coming forward offering them bags of money and they have to keep going somehow. They've reduced their staff to a bare minimum, even getting rid ...more  
Comment by Yoly900 on Nov 09, 2022 7:25pm
Failure is here especially for the shareholders that been holding the fkn bag 7-10 years they're nothing but slime crooks all of them 
Comment by ScienceFirst on Nov 09, 2022 8:05pm
Excellent post Gebremeskel.
Comment by ScienceFirst on Nov 09, 2022 9:27pm
Gebremeskel ... Again, excellent post.  All possible scenario.   The only thing that makes me consider another scenario is the fact that Roger and Kristina invested with their own money back in May and also again participated in the Sept. pp, with Dr. Mandel.   Kind of like if they've been reassured by the FDA of not to worry that much about the first 12 patients if the other ...more  
Comment by ScienceFirst on Nov 09, 2022 5:39pm
Indeed.  Excellent post Gebremeskel. TLT went into many tiny details to increase chances of success, minimize costs, adjust asap, think outside the box, solve issues, etc ...  Like these: - chosing a molecule (TLD-1433) that works both in oncology and anti-virus - chosing a molecule (TLD-1433) that, when mixed with transferrin, becomes even more potent, without having more side-effects ...more  
Comment by N0taP00p on Nov 09, 2022 6:16pm
@SF. I'll read all that soon. Really. @gebremeskel: Thanks. Yes, I've paid attention and owned shares for ~ 7 years. FGP gave some good (recent) examples of the issues. Eoganacht could probably consult with them on how to show data. Let's hope we are pleasantly surprised this quarter. That's what we all want.
Comment by gebremeskel on Nov 09, 2022 3:14pm
Because, contrary to appearances, you're not a P00p are you? Just a bubbly and brilliant basement boy looking for a good time  :)
Comment by Yoly900 on Nov 09, 2022 11:28am
Absolutely excuses after excuses they're the ones holding this down on offer. They will keep giving excuses and more raises next year with more warrant extensions crooooooooks all way fk them
Comment by Longholder99 on Nov 09, 2022 12:12pm
NOtaP00p = bot. IMO. Easy ignore decision.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250